activity of K + channels within vascular smooth muscle cells to elicit hyperpolarization and thereby a decline in L-type Ca 2+ channel activity, [Ca 2+ ] i and tone development (reviewed by Félétou & Vanhoutte, 1999) . There is considerable evidence that NO stimulates large conductance Ca 2+ -activated K + (BK Ca ) channel activity of vascular smooth muscle cells (Robertson et al. 1993) due to: (1) direct effects of NO on channel gating (Lang et al. 2000) ; (2) phosphorylation by cGMP-dependent protein kinase (PKG; Robertson et al. 1993) ; and/or (3) modulation of SR Ca 2+ release leading to an increased frequency of Ca 2+ sparks (Porter et al. 1998) . However, other K + channel types, including ATP-sensitive K + channels (Murphy & Brayden, 1995) and delayed rectifier K + (K DR ) channels (Zhao et al. 1997; Sobey & Faraci, 1999; Lovren & Triggle, 2000) , have also been suggested to play a role in mediating endothelium-dependent vasorelaxation due to NO. For example, in the rat basilar artery in vivo, endotheliumdependent relaxations in response to ACh were inhibited by 4-AP (200 mM), and thus a role for K DR channels in mediating the effects of endothelium-derived NO was proposed (Sobey & Faraci, 1999) . The stimulation of K DR channel activity was postulated to be due to a signalling cascade involving activation of guanylyl cyclase, cGMP, PKG and phosphorylation of the channels or associated modulatory subunits (Sobey & Faraci, 1999) . Previous studies provide compelling evidence for the modulation of vascular K DR channels by serine/threonine kinase-mediated phosphorylation, for example by cAMP-dependent (PKA) and Ca 2+ /phospholipid-dependent (PKC) protein kinase (Aiello et al. 1995 (Aiello et al. , 1998 Clément-Chomienne et al. 1996) . However, direct evidence for their modulation by a pathway involving cGMP and PKG is lacking.
In this study, the hypothesis that endothelium-dependent NO release produces relaxation of the rat basilar artery via a modulation of K DR channel activity was tested using wire myography and intracellular microelectrode recordings. Although we found that 4-AP depressed ACh-induced endothelium-dependent relaxation of rat basilar artery, the data were not consistent with the view that K DR channel activity was modulated by NO released from the endothelium. Rather, our findings suggest a novel, alternative explanation for the depression of endothelium-dependent relaxation by 4-AP. Specifically, our findings suggest that electrotonic communication of the depolarization due to 4-AP treatment from the smooth muscle cells to the endothelial layer via myo-endothelial gap junctions results in a depression of endothelium-dependent relaxation due to a suppression of NO synthesis and/or release.
METHODS

Tissue preparation
Male Sprague-Dawley rats (300-350 g) were maintained and killed by halothane inhalation and exsanguination according to the standards of the Canadian Council on Animal Care and a protocol reviewed by the Animal Care Committee of the Faculty of Medicine, The University of Calgary. Basilar arteries were gently removed, placed in ice-cold Krebs buffer and carefully cleaned of adherent connective tissue. The Krebs solution contained (mM): NaCl, 120; KCl, 4.8; NaHCO 3 , 25; NaH 2 PO 4 , 1.2; MgSO 4 , 1.2; glucose, 11; and CaCl 2 , 1.8.
Wire myography
For wire myograph studies, basilar arteries were cut into segments (2 mm in length) and mounted between two tungsten wires (40 mm in diameter) in a Mulvany-Halpern myograph (J. P. Trading, Denmark) for recording of isometric tension. Tissues were maintained at 37°C in 5 ml of oxygenated (95 % O 2 -5 % CO 2 ) Krebs buffer and resting tension was set to approximately 2 mN. Cumulative concentration-response relations for ACh, authentic NO (applied as bolus doses), sodium nitroprusside (SNP) and diethylamineNONOate (DEANONOate) were determined using arterial segments preconstricted with 5-hydroxytryptamine (5-HT; 0.1-1 mM) at a concentration that produced 75 % of maximal contraction. Peak relaxations in response to ACh were determined for each concentration and normalized to developed tension to obtain the percentage relaxation. To determine the concentration of 5-HT that would produce 75 % level of peak contraction, complete dose-response curves were determined for 26 tissues with an average peak developed force of 6.9 ± 0.3 mN observed with 3 mM 5-HT; the 75 % value, 5.3 mN, was obtained on average with 0.1-0.3 mM 5-HT. In some instances, it was necessary to adjust the concentration of 5-HT to obtain a similar level of precontraction in the presence of inhibitors as observed under control conditions. Contractility data were recorded to hard disk and analysed via a Powerlab A/D convertor and software (ADInstruments, USA).
Membrane potential recordings
For measurement of smooth muscle and endothelial cell membrane potential, basilar arteries were cut open longitudinally and pinned to the bottom of a Sylgard chamber, endothelial surface uppermost. Tissues were maintained at 37°C and constantly perfused with warmed Krebs buffer at a rate of 5 ml min _1 . Measurements of membrane potential were made with sharp glass microelectrodes, back-filled with 3 M KCl and with resistances of 60-100 MV. All data were recorded through a Powerlab (ADInstruments) and stored on disk. Drugs were added either as bolus doses or to the perfusate as indicated.
Solutions and chemicals
All drugs were obtained from Sigma Chemical Co. (St Louis, MO, USA) except for DEANONOate (Cayman Chemical Company, USA). All drugs were dissolved in Krebs solution except for DEANONOate, which was dissolved in degassed distilled water and, pinacidil and 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one (ODQ), which were dissolved in DMSO and then diluted in Krebs solution to the desired concentration (DMSO at the maximal final dilution of 0.1 % had no effect on 5-HT-induced contraction (control 6.9 ± 1.0 mN versus DMSO 7.2 ± 1.1 mN; n = 5; P > 0.05) or ACh-induced relaxation (control 95.4 ± 2.3 % versus DMSO 90.8 ± 3.5 % at 1 mM ACh; n = 3; P > 0.05)). All Krebs solutions containing 4-AP were checked for appropriate pH of 7.4. Solutions of authentic NO were prepared by injecting research grade NO gas (Praxair, Canada) into deoxygenated H 2 O. Authentic NO solutions were injected into the myograph close to the arterial segments and in volumes of less than 250 ml.
Statistics
For wire myograph studies, all data were expressed as means ± S.E.M. of n rats with only one tissue per rat employed for a given experimental group. Changes in membrane potential (in mV) were expressed as means ± S.E.M. of the number of rats. The statistical significance of all differences between mean values was calculated using Student's paired t test or repeated measures ANOVA followed by Bonferonni's post hoc test. A level of P < 0.05 was considered to be statistically significant.
RESULTS
Effect of 4-AP on endothelium-dependent relaxations in response to ACh
As shown in Fig. 1 , ACh (1 nM to 1 mM) evoked concentration-dependent relaxation of segments of basilar artery precontracted with 5-HT. Removal of the endothelium prevented relaxation in response to ACh (data not shown) and the relaxations were significantly inhibited in the presence of L-NNA (100 mM) or ODQ (10 mM; Fig. 1 ), but not indomethacin (data not shown). Mean cumulative concentration-relaxation curves for ACh in the absence and presence of L-NNA and ODQ are shown in Fig. 1 . Maximal relaxation was reduced from ~90 and ~88 to ~18 (n = 14; P < 0.01) and ~26 % (n = 13; P < 0.01) in L-NNA and ODQ, respectively. Several tissues showed complete suppression with L-NNA alone (e.g. representative data of Fig. 1 ), but on average, relaxation in response to ACh was still observed. Complete suppression of endotheliumdependent relaxation was obtained, however, with the combination of L-NNA and N G -nitro-L-arginine methyl ester (L-NAME; 100 mM; Fig. 1 ).
Application of 4-AP (300 mM) induced an increase in basal tone in 6 of 11 basilar artery segments studied (mean increase 2.6 ± 0.4 mN; n = 11 arteries) and regular oscillations in tone development following 4-AP exposure were observed in some tissues (Fig. 2) . In the presence of 4-AP, relaxations in response to ACh were significantly inhibited, with the maximal response reduced from ~92 tõ 33 % (n = 11; P < 0.01; Fig. 2 ). Pretreatment with tetrodotoxin (10 mM; n = 5) or selective inhibition of neuronal Kv1.1 subunit-containing K DR channels with k-dendrotoxin (Akhtar et al. 2002 ; 10 nM; n = 3) were without effect on basal tone or ACh-induced relaxations in the absence or presence of 4-AP (data not shown). We also employed clofilium for comparison with 4-AP; this drug inhibits recombinant Kv1.2 and Kv1.5 channels (Malayev et al. 1995; Yamagishi et al. 1995) and these channel Myo-endothelial coupling in rat basilar artery subunits are expressed by vascular myocytes . Clofilium at 3 mM (n = 5) inhibited AChinduced relaxation, in a similar way to the suppression produced with 4-AP (Fig. 2 ), but it had no effect on relaxations produced by the putative BK Ca channel activator, NS1619 (30 mM; n = 4) up to the maximal concentration tested of 10 mM (data not shown).
Effect of 4-AP on relaxations in response to exogenous NO
To test whether NO released from the endothelium modulated vascular K DR channel activity, exogenous NO donors were applied to vessel segments in the absence and presence of 4-AP (300 mM). If K DR channels contributed to the relaxation induced by endothelium-derived NO, we reasoned that relaxations in response to authentic NO, or a NO donor, would be similarly depressed by 4-AP. However, in contrast to ACh, relaxations of basilar artery segments in response to authentic NO (1 nM to 1 mM; n = 11), SNP (1 nM to 3 mM; n = 5) or DEANONOate (1 nM to 0.3 mM; n = 3) were not inhibited by 4-AP (300 mM). Figure 3 shows a representative recording for authentic NO and mean cumulative concentration-relaxation curves for authentic NO, SNP and DEANONOate in the absence and presence of 4-AP. Similarly, clofilium (3 mM) did not affect relaxations in response to authentic NO (n = 4; data not shown).
Prevention of 4-AP-induced inhibition of relaxation in response to ACh by pinacidil
To assess the role of membrane potential depolarization as a cause of the inhibition of ACh-induced endotheliumdependent relaxation induced by 4-AP, the K + channel opener, pinacidil, was employed to activate ATP-sensitive K + channels and evoke hyperpolarization within the vessel segments. Pinacidil was applied in increasing concentrations until reversal of 4-AP-induced (300 mM) increase in basal tension was observed (relaxation was noted at 1 mM pinacidil in most tissues). Significantly, in the combined presence of pinacidil and 4-AP, the inhibitory effect of K DR channel inhibition on ACh-evoked relaxations of segments of basilar artery was not apparent. A representative trace illustrating the lack of effect of 4-AP on ACh-induced relaxations in the presence of pinacidil and mean concentration-relaxation curves for ACh in the presence and absence of 4-AP and pinacidil (1 mM; n = 5) are shown in Fig. 4 .
Prevention of 4-AP-induced inhibition of AChinduced relaxation by 18bGA
Endothelial cells are not thought to express voltage-gated K + channels (Himmel et al. 1993; Nilius & Droogmans, 2001 ) and for this reason we felt that the depolarization was not due to a direct effect of 4-AP on endothelial cell membrane potential. However, we reasoned that AChinduced relaxation might be inhibited indirectly if the depolarization evoked by 4-AP inhibition of smooth muscle K DR channels was communicated to the endothelium via electrical coupling by myo-endothelial gap junctions. To test this hypothesis, ACh was applied in the combined presence of 4-AP and the gap junction uncoupling agent, 18bGA (Davidson & Baumgarten, 1988; Guan et al. 1996; Yamamoto et al. 1998) . In preliminary experiments, 18bGA was found to depress 5-HT-induced contractions in a concentration-dependent fashion between 10 and 50 mM, probably as a result of nonspecific inhibition of tone development, as previously reported (Chaytor et al. 2000; Tare et al. 2002) . However, at 5 mM, no effect on 5-HT-induced tone development (control 8.4 ± 0.7 versus 18bGA 8.3 ± 0.6 mN; n = 4; P > 0.05) or ACh-induced relaxation (control 78.4 ± 2.3 versus 18bGA 82.7 ± 9.8 % with 1 mM ACh; n = 3; P > 0.05) was observed, so this concentration was employed to determine the effect on endothelium-dependent relaxation in the presence of 4-AP. Treatment with 18bGA was found to prevent the inhibitory effect of 4-AP (300 mM) on ACh-induced relaxation. A representative recording and mean concentrationrelaxation curves for ACh in the presence of 4-AP and 18bGA are shown in 
Effect of 4-AP on membrane potential of endothelial and vascular smooth muscle cells of rat basilar artery
To directly assess the effect of 4-AP on the membrane potential of vascular smooth muscle and endothelial cells of rat basilar artery and to determine if the gap junction uncoupling drug, 18bGA, would prevent depolarization of the endothelium by 4-AP, segments of rat basilar artery were opened and impaled with sharp microelectrodes from the luminal surface. In most cases, the endothelial cells were the first cells to be impaled using this approach and recordings of smooth muscle membrane potential were obtained by further advancing the pipette into the vessel wall. To confirm the specific cell type impaled during each recording, the response of membrane potential to BayK8644 (1 mM), an activator of L-type voltage-gated Ca 2+ channels, was determined in the absence and presence 18bGA (5 mM). The rationale for the use of BayK8644 was as follows: L-type Ca 2+ channels are expressed by vascular smooth muscle but not by endothelial cells (Nilius & Droogmans, 2001) , so BayK8644 would be not expected to depolarize endothelial cells in the absence of electrical communication with the underlying smooth muscle cells. The representative recordings of Fig. 6 show that BayK8644 (1 mM) depolarized both endothelial and smooth muscle cells, but in the presence of the gap junction uncoupler, 18bGA (5 mM), only the membrane potential of smooth muscle cells was affected by the Ca 2+ channel activator. The resting membrane potential of endothelial cells was depolarized compared to that of smooth muscle cells under control conditions (Table 1) . BayK8644 caused depolarization of endothelial and smooth muscle cells by +10.4 ± 1.2 and +12.9 ± 1.5 mV, respectively (Table 1) . Application of 18bGA (5 mM) induced a small, but significant depolarization of +4.1 ± 1.1 mV in endothelial cells (P < 0.01), but it had no effect on smooth muscle cell membrane potential (Table 1 ). In the presence of 18bGA, however, the membrane potential of endothelial cells was unaffected by BayK8644, but the membrane potential of vascular smooth muscle cells exhibited a depolarization of +14.2 ± 1.4 mV (P < 0.01; Table 1 ). In contrast to BayK8644, application of 5-HT (10 mM) had only a minimal effect on membrane potential of smooth muscle cells (+2.1 ± 0.9 mV; n = 15).
The representative recordings of Fig. 7 show that application of 4-AP (200 mM) evoked a similar level of depolarization in endothelial and vascular smooth muscle cells of rat basilar artery by +11.0 ± 1.0 (P < 0.05) and +10.0 ± 1.0 mV (P < 0.05), respectively. Significantly, however, the depolarization of endothelial cells induced by 4-AP was reversed by 18bGA (5 mM), whereas uncoupling gap junctions had no effect on the depolarization of the smooth muscle cells. Similarly, Fig. 7 shows that if 18bGA
Myo-endothelial coupling in rat basilar artery J. Physiol. 545.3 was added before the addition of 4-AP, then the magnitude of the depolarization of endothelial cells was reduced. Under control conditions, 4-AP depolarized endothelial cells by +12.4 ± 3.9 mV (n = 6), but after treatment with 18bGA, 4-AP treatment had no effect on membrane potential (Table 2 ). In contrast, application of 4-AP depolarized smooth muscle cells by +9.2 ± 1.1 mV before, and by a similar magnitude of +10.5 ± 1.1 mV after, treatment with 18bGA ( Table 2) .
Effect of 4-AP on ACh-induced hyperpolarization of endothelium and vascular smooth muscle cells of rat basilar artery
As shown in Fig. 8 , bolus doses of ACh (10 mmol) caused transient hyperpolarizations of the membrane potential of endothelial and smooth muscle cells that were of a similar peak amplitude of approximately _10 mV (Table 3 ). The hyperpolarization of endotheliaI cells was unaffected by treatment with L-NNA, but hyperpolarization of smooth muscle cells was completely blocked (Table 3 ). These data indicate that the hyperpolarization of the smooth muscle cells in response to ACh was due to NO released from the endothelium. In the presence of 4-AP (200 mM), the _37.4 ± 1.5 _27.0 ± 2.0 † +10.4 ± 1.2 _49.9 ± 2.2 _37.0 ± 2.6 † +12.9 ± 1.5 18bGA (n = 38, 38) _37.8 ± 0.9 _32.7 ± 0.7 ‡ +4.1 ± 1.1 _49.1 ± 1.1 _48.8 ± 1.0 +0.3 ± 1.0 18bGA + BayK8644 (n = 38, 38) _32.3 ± 1.0 _29.0 ± 1.2 +3.3 ± 0.9 § _49.0 ± 1.7 _34.8 ± 2.0 ‡ +14.2 ± 1.4 * Significantly different from smooth muscle cell membrane potential (P < 0.01). † Significantly different from value before BayK8644 (P < 0.01). ‡ Significantly different from value before 18bGA (endothelium) or 18bGA + BayK8644 (vascular smooth muscle; P < 0.01). § Significantly different from value in BayK8644 but absence of 18bGA (P < 0.01). membrane potential of both cell types was significantly depolarized and the hyperpolarizations induced by ACh did not reach the level of membrane potential attained in the absence of 4-AP. Additionally, 4-AP did not alter the magnitude of the ACh-induced hyperpolarization of endothelium, but the magnitude of smooth muscle hyperpolarization was significantly reduced ( Fig. 8 and Table 3 ). To quantify the change in ACh-induced hyperpolarization in the presence of 4-AP, the amplitude and duration of the hyperpolarization were simultaneously considered by calculating the area under the curve for the endothelial and smooth muscle hyperpolarizations. Endothelial and smooth muscle cell hyperpolarization induced by ACh were significantly reduced from 2164 ± 141 to 1156 ± 80 mV s (n = 9; P < 0.01) and from 4427 ± 367 to 1982 ± 210 mV s (n = 9; P < 0.01), respectively by 4-AP. Thus, 4-AP reduced the extent of ACh-induced hyperpolarization of the endothelium and smooth muscle cells, as well as shifting the range over which the hyperpolarizations occurred to more positive potentials. Application of 18bGA did not alter hyperpolarization of endothelial or smooth muscle cells in response to ACh, indicating that myo-endothelial gap junctional coupling is not required for endotheliumdependent relaxation in rat basilar artery (n = 6). However, in the combined presence of 4-AP and 18bGA, ACh-induced hyperpolarization of smooth muscle cell membrane potential (_12.3 ± 1.6 mV) was significantly greater than in 4-AP alone (_6.5 ± 1.1 mV; Fig. 8 and Table 3 ). Additionally, the area under the curves for AChMyo-endothelial coupling in rat basilar artery 4-AP (n = 15, 11) _38.9 ± 1.4 _27.9 ± 0.7 † +11.0 ± 1.0 _46.3 ± 1.8 _36.4 ± 1.8 † +10.0 ± 1.0 4-AP (before 18bGA) (n = 6, 6) _40.2 ± 1.9 _27.8 ± 2.0 † +12.4 ± 3.9 _43.4 ± 2.5 _34.2 ± 2.4 † +9.2 ± 1.1 4-AP (after 18bGA) * (n = 6, 6) _34.7 ± 1.7 _33.0 ± 1.4 +1.7 ± 1.0 ‡ _47.4 ± 2.7 _36.9 ± 3.3 † +10.5 ± 1.1 * Paired impalements maintained during 4-AP application in the absence and presence of 18bGA. † Significantly different from value of membrane potential in the absence of 4-AP (P < 0.01). ‡ Significantly different from change in membrane potential due to 4-AP in the absence of 18bGA (P < 0.01). 
DISCUSSION
This study makes the novel observation that depolarization of vascular smooth muscle cells of the rat basilar artery due to inhibition of K DR channels with 4-AP, or the activation of L-type Ca 2+ channels with BayK8644, leads to a corresponding depolarization of endothelial cell membrane potential due to electrical communication between the two cell types via myo-endothelial gap junctions. Significantly, depolarization of the endothelium in the presence of 4-AP was associated with a depression of ACh-induced endothelium-dependent relaxation mediated by NO. Based on our findings, it is unlikely that vascular smooth muscle K DR channels mediate NO-induced hyperpolarization and relaxation of the rat basilar artery. Rather, the results indicate that 4-AP-induced smooth muscle depolarization may indirectly inhibit AChinduced relaxation via electrotonic depolarization of the endothelium and suppression of NO synthesis and/or release. The ability of endothelial cell hyperpolarization to affect smooth muscle membrane potential via myoendothelial gap junctional communication is well recognized as a potential mechanism to account for non-NO, non-prostanoid endothelium-dependent relaxation, i.e. relaxation due to an endothelium-dependent hyperpolarizing factor (reviewed by Bény, 1999; Félétou & Vanhoutte, 1999) . However, only limited evidence exists to indicate that electrical communication can occur in the reverse direction, from vascular smooth muscle cells to the endothelium, and the functional consequences of this coupling have not been assessed previously. The results of this study provide the first evidence that selective depolarization of vascular smooth muscle cells can influence the level of endothelial cell membrane potential and thereby endothelium function by reducing NOdependent control of vascular tone.
A substantial body of evidence indicates that endotheliumdependent relaxation of arterial smooth muscle is mediated by at least three different factors/mechanisms, including NO, prostacyclin and an as-yet-unidentified endothelium-derived hyperpolarizing factor, which may be a P450-derived epoxide, K + or myo-endothelial gap junctional electrical coupling (Edwards et al. 1998; Coleman et al. 2001; Fleming, 2001) . Endotheliumdependent relaxation of the rat basilar artery evoked by ACh was shown to be completely suppressed by inhibition of NOS by the combination of L-NNA and L-NAME, and by the inhibitor of soluble guanylyl cyclase, ODQ, but not by indomethacin or 18bGA. This indicates that in this vessel, endothelium-dependent relaxation is exclusively due to the release of NO. There is compelling evidence that BK Ca channels are important effectors of the action of NO in mediating vascular smooth muscle hyperpolarization and relaxation in many vessels (Homer & Wanstall, 2000) . This role for BK Ca was established in part by experiments showing that the specific BK Ca inhibitor iberiotoxin suppressed endothelium-dependent relaxation induced by NO (Khan et al. 1993; Bialecki & Stinson-Fisher, 1995; Kitazono et al. 1997; Li et al. 1997; Satake et al. 1997) . A similar approach has been employed to define a role for other K + channels as effectors of endothelium-derived NO. For example, inhibition of ACh-evoked relaxation by 4-AP was interpreted to indicate that K DR channels mediate NO-induced relaxation of rat basilar arteries in vivo (Sobey & Faraci, 1999) . In the light of the present data, however, this mechanism would not appear to be involved. This view is based on the lack of effect of 4-AP on relaxations evoked by exogenous sources of NO, including J. Physiol. 545.3 Table 3 . Effect of 4-AP on ACh-induced hyperpolarization of endothelial and vascular smooth muscle cell membrane potential (mV) in the absence and presence of 18bGA
Endothelium
Vascular smooth muscle Before After D Before After D ACh (n = 3, 3) _35.7 ± 1.8 _47.3 ± 1.0 † _11.7 ± 1.1 _43.3 ± 3.0 _55.2 ± 2.0 † _11.8 ± 1.6
ACh + L-NNA * (n = 3, 3) _35.3 ± 2.4 _44.3 ± 2.4 † _12.0 ± 1.8 _40.7 ± 2.4 _41.5 ± 3.1 ‡ _0.8 ± 1.0 ‡ ACh (n = 16, 16) _39.8 ± 1.2 _48.5 ± 1.6 † _9.5 ± 1.1 _46.1 ± 1.4 _56.4 ± 0.7 † _10.3 ± 1.1
ACh + 4-AP (n = 9, 9) _27.1 ± 1.1 § _37.8 ± 1.1 † § _7.9 ± 0.9 _33.8 ± 2.1 § _40.5 ± 2.1 † § _6.5 ± 1.1 § ACh + 4-AP and 18bGA (n = 4, 4) _39.0 ± 2.1 ¶ _52.0 ± 1.8 † _12.3 ± 1.0 ¶ _35.3 ± 2.0 _47.5 ± 1.9 † ¶ _12.3 ± 1.6 ¶ * Impalements maintained during 4-AP application in the absence and presence of L-NNA. † Significantly different from value of membrane potential in the absence of ACh (P < 0.01). ‡ Significantly different from change in membrane potential due to ACh in the absence of L-NNA (P < 0.01). § Significantly different from value in the absence of 4-AP (P < 0.01). ¶ Significantly different from value in the presence of 4-AP (P < 0.01).
authentic NO, sodium nitroprusside and DEANONOate. Similar results with 1 mM 4-AP and DEANONOate were previously reported by Hemplemann et al. (2001) . In the absence of a role for K DR channels in mediating the effect of NO on rat basilar arterial smooth muscle cells, an alternative explanation for the suppression of ACh-evoked endothelium-dependent relaxation by 4-AP is required.
This study indicates that membrane potential depolarization underlies the suppression of endothelium-dependent relaxation by 4-AP. Pinacidil was employed to activate ATP-sensitive K + channels and hyperpolarize vascular smooth muscle cells (Nelson & Quayle, 1995) and was found to prevent the suppression of ACh-evoked relaxation by 4-AP. This indicates that depolarization of the vascular smooth muscle cells and/or the endothelium by 4-AP was responsible for the suppression of endothelium-dependent relaxation by NO. This is consistent with previous observations showing that depolarization of pulmonary arteries with elevated extracellular potassium (25 mM) blocked endotheliumdependent relaxation (Seiden et al. 2000) . Depolarization of the basilar arterial smooth muscle cells by 4-AP per se did not block the actions of endothelium-derived NO on the myocytes because 4-AP-induced-depolarization had no effect on relaxations in response to exogenous NO. Alternatively, depolarization of the endothelium is known to reduce NO synthesis and/or release. Previous studies show that NO synthesis and/or release is dependent on a rise in intracellular [Ca 2+ ] i in endothelial cells, that Ca 2+ influx is required for sustained endothelium-dependent relaxation, and that this Ca 2+ influx is decreased by endothelial cell depolarization (Adams et al. 1989; Lückhoff & Busse, 1990b; Wang & Van Breeman, 1999) . Endothelial Ca 2+ influx is not mediated by voltagedependent Ca 2+ channels and is not activated by depolarization. Rather, hyperpolarization appears to be required, in part to maintain an appropriate electrochemical driving force for ACh-induced Ca 2+ influx through a nonselective cation conductance (Schilling, 1989; Kamouchi et al. 1999; Wang & Van Breeman, 1999) , but it may also prevent Ca 2+ entry by channel inactivation and/or reduction in unitary conductance. The latter is suggested by the fact that the decline in Ca 2+ influx with depolarization positive tõ _35 mV exceeds that which can be explained by a reduction in driving force (Oike et al. 1994; Wang & Van Breeman, 1999) . According to these observations, a reduction in basal and agonist-evoked NO release would accompany endothelial depolarization from _39 to _27 mV under resting conditions and reduction in AChinduced peak hyperpolarization from _49 to _38 mV in the presence of 4-AP. A limitation in this study is the lack of direct measurements to confirm the suppression of ACh-induced NO release from the basilar arterial endothelium by 4-AP treatment. However, the present results provide indirect evidence that NO release was reduced. First, the ACh-induced hyperpolarization of smooth muscle cells was blocked by L-NNA, indicating that it was induced by NO. Second, both the amplitude and the area under curve for the ACh-induced smooth muscle hyperpolarization were significantly reduced in the presence of 4-AP, suggesting that the magnitude of NO release was reduced.
It is unlikely that a direct effect of 4-AP on endothelial K + channels was responsible for the depolarization observed in this study. This is based on: (1) the lack of effect of 4-AP on the membrane potential of endothelial cells in the presence of 18bGA; and (2) the lack of evidence of 4-APsensitive K DR channels in endothelial cells (Nilius & Droogmans, 2001 ) despite immunocytochemical evidence of voltage-gated K + channel subunit expression in the endothelium of some resistance arteries and capillaries (Fan & Walsh, 1999; Cheong et al. 2001 ) and reports of their presence in cultured endothelial cells (Takeda et al. 1987; Hogg et al. 1999) . Nonspecific effects would also seem to be an unlikely explanation for the suppression of ACh-induced relaxation by 4-AP. Although 4-AP is widely employed as an inhibitor of voltage-gated K + channels in smooth muscle and other cell types (Nelson & Quayle, 1995) , actions unrelated to channel block were previously reported and its selectivity and suitability for use in intact tissue and/or cell preparations has been questioned (e.g. Wood & Gillespie, 1998) . However, the concentration of 4-AP (200 or 300 mM) used in this study is consistent with the IC 50 for inhibition of K DR currents of vascular myocytes , and significantly lower than that associated with reduced Ca 2+ release, intracellular pH and/or BK Ca channel activity (i.e. 5-20 mM; PetkovaKirova et al. 2000; Quignard et al. 2000; Ghisdal & Morel, 2001) . Additionally, clofilium (3 mM) was also employed to selectively inhibit K DR channels and found to mimic the actions of 4-AP treatment. For this reason, it is unlikely that 4-AP affected endothelial or vascular smooth muscle cell function via a mechanism(s) unrelated to an inhibition of smooth muscle K DR channels.
The electrophysiological data obtained in this study are consistent with the view that the inhibition of endothelium-dependent relaxation by 4-AP was the result of an indirect effect on endothelial cell membrane potential mediated by electrical coupling through myoendothelial gap junctions. We employed 18bGA to uncouple gap junctions and to prevent myo-endothelial gap junctional communication based on the previous findings showing a phosphatase-mediated dephosphorylation of connexins and loss of cell-to-cell coupling via disassembly of gap junction plaques with this agent (Guan et al. 1996) . 18bGA was found to prevent and/or reverse endothelial cell depolarization induced by 4-AP or BayK8644, but it did not affect smooth muscle cell depolarization by these treatments. These results indicate Myo-endothelial coupling in rat basilar artery that uncoupling myo-endothelial gap junctions can prevent endothelial cell depolarization as a result of the selective depolarization of smooth muscle cells by two distinct mechanisms, inhibition of K DR channels and activation of L-type Ca 2+ channels. Moreover, in the presence of 18bGA, we found that the inhibition of AChinduced hyperpolarization and relaxation by 4-AP was significantly reduced. This indicates that uncoupling myoendothelial gap junctions permitted a recovery of endothelium function despite the presence of maintained smooth muscle depolarization due to 4-AP. We do not attribute the effect of 18bGA to the nonspecific effects on membrane potential (Tare et al. 2002) and tone development (Chaytor et al. 2000) that were noted when this drug was employed at 50-100 mM. We approached the use of 18bGA with caution and used a concentration of 5 mM that did not: (1) cause relaxation of arterial segments precontracted with 5-HT; (2) alter the extent of AChinduced relaxation or sensitivity to ACh; or (3) change smooth muscle membrane potential. 18bGA did cause a slight depolarization of basilar arterial endothelial cells, but at approximately +4 mV, the change in membrane potential was much smaller than the +30 mV depolarization observed with higher concentrations (Coleman et al. 2001) . We attribute this +4 mV depolarization to the uncoupling of the endothelium from the hyperpolarizing influence of the underlying smooth muscle cells, as previously reported (Popp et al. 1996; Yamamoto et al. 1998) .
The role of the endothelium in control of vascular smooth muscle contractility in health is well established and dysfunctional regulation of arterial tone development due to abnormal endothelial function and reduced NO release is recognized to be a important cause of abnormal contractility associated with vascular disease (Vanhoutte, 1997; Schiffrin, 2001; Baron, 2002) . This study shows for the first time that vascular smooth muscle cell membrane depolarization can alter endothelial function. The presence of myo-endothelial gap junctions between endothelial and smooth muscle cells of several arteries has been identified (e.g. Sandow & Hill, 2000) , and these structures are present in the rat basilar artery (S. L. Sandow & C. E. Hill, unpublished observations). Moreover, previous studies have shown that changes in arterial smooth muscle membrane potential can be communicated to endothelial cells in several vessels (von der Weid & Bény, 1993; Bény & Pacicca, 1994; Marchenko & Sage, 1994; Murai et al. 1999; White & Hiley, 2000) . For example, noradrenaline-induced depolarization (rat aorta; Marchenko & Sage, 1994) and levcromakalim-induced hyperpolarization (rabbit and rat mesenteric arteries; Murai et al. 1999; White & Hiley, 2000) were reported to be transmitted from smooth muscle to endothelial cells. However, the physiological and pathophysiological significance of smooth muscle control of endothelial function via myo-endothelial gap junction communication has not been addressed previously. In the present study, 4-AP was found to cause an impairment of agonist-induced, endothelium-dependent regulation of tone development in the rat basilar artery. Based on this novel finding, it would seem worthwhile to consider the possibility that abnormal smooth muscle depolarization in disease may contribute to a loss of endothelium-dependent control of arterial tone development, for example, as a result of depressed smooth muscle K + channel, or enhanced Ca 2+ channel, activity and/or expression (Smirnov et al. 1994; Platoshyn et al. 2001) . NO is also known to have additional roles within blood vessels, including control of proliferation and phenotype, and abnormal NO synthesis and/or release due to smooth muscle depolarization and electrotonic depolarization of the endothelium could also contribute to dysfunctional regulation of vasculogenesis, atheroscelerosis and retinopathy. To address these possibilities, further studies will be required to determine: (1) the electrical properties, such as the ratio of electrical impedance between the endothelium and smooth muscle layers, as well as the level of myo-endothelial gap junctional conductance, that are required for control of endothelial membrane potential by vascular smooth muscle; and (2) whether the properties of the endothelium, smooth muscle cells and myo-endothelial gap junctions of other arteries are appropriate for smooth muscle to endothelium communication in health and/or disease states.
